Contact EN 简 繁
  • About Us
    Our Mission Our Team Milestones
  • R&D
    Discovery Translational Research Process Development Clinical Development
  • Manufacturing
    T-BLOC ICB Platform Experience & Capacity
  • Pipeline
    Oncology Non-oncology TST001 TST002 TST003
  • Collaborations
  • Investors Relations
  • News
    Press Release In The News Scientific Publications
  • Careers
    Life in Transcenta Job Opportunity
  • About Us
    Our Mission Our Team Milestones
  • R&D
    Discovery Translational Research Process Development Clinical Development
  • Manufacturing
    T-BLOC ICB Platform Experience & Capacity
  • Pipeline
    Oncology Non-oncology TST001 TST002 TST003
  • Collaborations
  • Investors Relations
    Corporate Governance Announcements Stock Information Financial Reports Listing Documents IR Calendar Webcasts & Presentations Email Alert IR Contact
  • News
    Press Release In The News Scientific Publications
  • Careers
    Life in Transcenta Job Opportunity
  • Contact
  • EN
  • 简
  • 繁

Investors Relations

Investors Relations Corporate Governance Announcements Stock Information Financial Reports Listing Documents IR Calendar Webcasts & Presentations Email Alert IR Contact

Financial Reports

  • 2021 Annual Report

    2021 Annual Report

  •  2021 Interim Report

    2021 Interim Report

Investors Relations
  • Corporate Governance

  • Announcements

  • Stock Information

  • Financial Reports

  • Listing Documents

  • IR Calendar

  • Webcasts & Presentations

  • Email Alert

  • IR Contact

Stay tuned
© 2019 TRANSCENTA HOLDING ALL RIGHTS RESERVED.
浙ICP备16042385号-1

About Us

Our Mission Our Team Milestones

R&D

Discovery Translational Research Process Development Clinical Development

Manufacturing

T-BLOC ICB Platform Experience & Capacity

Pipeline

Oncology Non-oncology TST001 TST002 TST003

Collaborations

Investors Relations

News

Press Release In The News Scientific Publications

Careers

Life in Transcenta Job Opportunity